Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Manasa Ramakrishna
Affiliation
ORCID
Career Start Year
2008
Papers
35
H Index
28
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
32651564
Efficient recovery of the RNA-bound proteome and protein-bound transcriptome using phase separation (OOPS).
Nat Protoc
2020
31969649
Biotin proximity tagging favours unfolded proteins and enables the study of intrinsically disordered regions.
Commun Biol
2020
31755249
The cell stress response: extreme times call for post-transcriptional measures.
Wiley interdisciplinary reviews. RNA
2020
30988298
Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation.
Nat Commun
2019
30607034
Comprehensive identification of RNA-protein interactions in any organism using orthogonal organic phase separation (OOPS).
Nat Biotechnol
2019
31123356
Author Correction: Comprehensive identification of RNA-protein interactions in any organism using orthogonal organic phase separation (OOPS).
Nat Biotechnol
2019
29341429
Trans-acting translational regulatory RNA binding proteins.
Wiley Interdiscip Rev RNA
2018
30169671
Identification of the RNA polymerase I-RNA interactome.
Nucleic Acids Res
2018
28288110
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
Nat Med
2017
28329761
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.
Nature
2017
27498871
Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer.
Cell Rep
2016
27197245
Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.
Genome Res
2016
27136393
The topography of mutational processes in breast cancer genomes.
Nat Commun
2016
27135926
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nature
2016
27615322
Mutational signatures of ionizing radiation in second malignancies.
Nat Commun
2016
26018901
Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.
Nat Genet
2015
25642631
Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers.
Nat Genet
2015
25963125
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.
Genome Res
2015
26099045
Subclonal diversification of primary breast cancer revealed by multiregion sequencing.
Nat Med
2015
24728294
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
Nat Genet
2014
25271376
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.
Elife
2014
24413735
RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.
Nat Genet
2014
24633157
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
Nat Genet
2014
24714652
Processed pseudogenes acquired somatically during cancer development.
Nat Commun
2014
25082706
Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.
Science
2014
24148783
The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models.
Genome Biol
2013
22608083
The life history of 21 breast cancers.
Cell
2012
22608084
Mutational processes molding the genomes of 21 breast cancers.
Cell
2012
21575258
Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.
BMC Cancer
2011
20386695
Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.
PLoS ONE
2010
20844748
Copy number analysis identifies novel interactions between genomic loci in ovarian cancer.
PLoS One
2010
21139216
Crystallization and preliminary X-ray crystallographic analysis of zebrafish prototype galectin Drgal1-L2.
2010
19603523
Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Genes Chromosomes Cancer
2009
18953434
Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer.
Neoplasia
2008
18408720
No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas.
Nat Genet
2008
1 - 35 of 35
Column Actions
Search
Recommended Authors
Collaborators
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers
20
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Co-authored papers
19
Michael R Stratton
Wellcome Sanger Institute
Co-authored papers
18
Adam Butler
Wellcome Sanger Institute
Co-authored papers
15
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers
14
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers
14
Andrea L Richardson
Co-authored papers
13
Keiran Raine
Wellcome Sanger Institute
Co-authored papers
12
Patrick S Tarpey
Wellcome Trust Sanger Institute
Co-authored papers
12
Peter Van Loo
The Francis Crick Institute
Co-authored papers
12
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers
11
Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Co-authored papers
11
Jon Teague
Wellcome Sanger Institute
Co-authored papers
10
Andrew Menzies
Wellcome Sanger Institute
Co-authored papers
10
Laura Mudie
Wellcome Trust Sanger Institute
Co-authored papers
9
Gilles Thomas
Co-authored papers
9
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Co-authored papers
9
Susanna L Cooke
Institute of Cancer Sciences, University of Glasgow
Co-authored papers
9
David Jones
Wellcome Sanger Institute
Co-authored papers
9
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers
8
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Co-authored papers
8
Inigo Martincorena
Wellcome Sanger Institute
Co-authored papers
8
Moritz Gerstung
German Cancer Research Centre DKFZ
Co-authored papers
8
Sarah O'Meara
Clinical Research Facility, Mercy University Hospital
Co-authored papers
7
Paul N Span
Radboud University Medical Center
Co-authored papers
7
Adrienne M Flanagan
University College London, UCL Cancer Institute
Co-authored papers
7
Stuart McLaren
Wellcome Trust Sanger Institute
Co-authored papers
7
Sunil R Lakhani
University of Queensland
Co-authored papers
7
Kathryn S Lilley
University of Cambridge
Co-authored papers
6
Ian G Campbell
Co-authored papers
6
1 - 30